Quantitative Analysis of Survivin Protein Expression and Its Therapeutic Depletion by an Antisense Oligonucleotide in Human Lung Tumors
RNA-directed antisense and interference therapeutics are a promising treatment option for cancer. The demonstration of depletion of target proteins within human tumors in vivo using validated methodology will be a key to the application of this technology. Here, we present a flow cytometric-based ap...
Main Authors: | Anna L Olsen, Joanne M Davies, Louise Medley, David Breen, Denis C Talbot, Peter J McHugh |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2012-01-01
|
Series: | Molecular Therapy: Nucleic Acids |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2162253116300841 |
Similar Items
-
The Use of Antisense Oligonucleotides in Evaluating Survivin as a Therapeutic Target for Radiation Sensitization in Lung Cancer
by: Shinohara Eric T., et al.
Published: (2004-01-01) -
Delivery of a survivin promoter-driven antisense survivin-expressing plasmid DNA as a cancer therapeutic: a proof-of-concept study
by: Lin KY, et al.
Published: (2016-05-01) -
Down-regulation of Survivin by Antisense Oligonucleotides Increases Apoptosis, Inhibits Cytokinesis and Anchorage-Independent Growth
by: Jun Chen, et al.
Published: (2000-05-01) -
Effect of antisense oligodeoxynucleotide targeting survivin on growth of human gastric cancer cells
by: Lantao Xu
Published: (2013-01-01) -
THERAPEUTIC ANTISENSE OLIGONUCLEOTIDES AGAINST CANCER: HURDLING TO THE CLINIC
by: Pedro Miguel Duarte Moreno, et al.
Published: (2014-10-01)